RxDoctor Payments Data

Mahmoud Loghman-Adham

Pediatric Nephrology · Nutley, NJNPI 1043594120

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $443,152 of the $443,152 with a category attached, or 100.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 64.7% of it on its own, with 2 other manufacturers making up the rest.

$443,152in general payments, 2019–2025

Across 80 payments — averaging $5539.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$287K
  • American Regent$155K
  • Daiichi Sankyo Inc.$1K

What the payments were for

  • Consulting fees$443,152100%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.41$286,540
American Regent38$155,464
Daiichi Sankyo Inc.1$1,148

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric nephrology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Other pediatric nephrology in Nutley

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →